7-Chlorothieno[3,2-c]pyridin-4(5H)-one, 98%, 50mg

(R)-3-(4-Chloro-benzyloxy)-pyrrolidine hydrochloride, 100mg

METHYL (S)-2-(BOC-AMINO)-4-IODOBUTANOATE, 95.0%, 10g

6-(methylthio)-N-(tetrahydrofuran-2-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

(3-fluoro-4-(3-morpholinopropoxy)phenyl)boronic acid, 95.0%, 100mg

2-Amino-4,5-dimethylbenzoic acid, 95.0%, 25g

Methyl 2 bromobutyrate, 95%, 500g

(S)-1-(3-Fluorophenyl)-N-methylethanamine, 97%, 100mg

5-Chloropyrimidin-2(1H)-one hydrochloride, 95.0%, 5g

(2S)-[(TERT-BUTOXYCARBONYL)AMINO](4-HYDROXYPHENYL)ETHANOIC ACID, 95.0%, 5g

1,3,4,6-Tetrakis(methoxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione, 95.0%, 100g

Plan PLPHi 20x/0.40 phase contrast IOS infinity corrected objective

4,6-Diiodo-2-methylpyrimidine, 95.0%, 100mg